France· FR:66729097
PARLODEL 10 mg, gélule
A medicinal product containing mésilate de bromocriptine, registered in France by EXELTIS SANTE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉSILATE DE BROMOCRIPTINE
- Manufacturer
- EXELTIS SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400934742309plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 gélule(s)EUR 9.98
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mésilate de bromocriptine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBromocriptine 10mg capsulesDowelhurst Ltd
- BelgiumParlodel 10 mgExeltis Germany
- FinlandParlodelMeda Oy
- NorwayParlodelMeda
- United StatesBromocriptine mesylateSandoz Inc
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- SwedenParlodel 2,5 mg TablettEbb Medical AB
- PolandBromocornFarmaceutyczna Spółdzielnia Pracy FILOFARM
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Netherlands · Parlodel
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Sweden · Pravidel
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5307cced-303a-46c6-b2bf-bc033593b1ea GET /v1/drugs/5307cced-303a-46c6-b2bf-bc033593b1ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66729097",
"date_amm": "1981-06-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉSILATE DE BROMOCRIPTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mésilate de bromocriptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.